Lincoln Pharmaceuticals Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Munjal Mahendrabhai Patel, was filed 06 Jun 2024.
Lincoln Pharmaceuticals Limited: what insiders have been doing
Lincoln Pharmaceuticals Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). No insider at Lincoln Pharmaceuticals Limited has published a filing in the past twelve months. The most recent one dates from 6 June 2024.
Looking back to 2021, when coverage begins, insiders filed 131 purchases and 6 sales.
Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -20.1%Entry ₹358.40 · Close at T+365 ₹286.40
- -20.1%Entry ₹358.40 · Close at T+365 ₹286.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 13,500 shares@ ₹541.502.8% of flowEquity SharesSEBI:2ca919135ef08c3413a0afd0274537f89e53bc25Canonical exit: 2 Sept 2024 (T+90)
- 15,000 shares@ ₹564.603.3% of flowEquity SharesSEBI:fffe31cdb6fe15868353c446cbdbff67454b23baCanonical exit: 29 Aug 2024 (T+90)
- 20,000 shares@ ₹568.254.4% of flowEquity SharesSEBI:66afd8c29418ca07eff03dadca13cc87feae9524Canonical exit: 1 Sept 2024 (T+90)
- 1,000 shares@ ₹733.5049.7% of flowEquity SharesSEBI:da764219cb9bd4fe3172c42348903d43e666e5f8
- 1,000 shares@ ₹751.1450.3% of flowEquity SharesSEBI:e435230cbd396eebb77476731e4f8535fa2ef364
- 1,500 shares@ ₹747.29100.0% of flowEquity SharesSEBI:6dd714e90b4e5b2f5b413baa25947f3fdc0faee4
- 20,000 shares@ ₹641.0040.8% of flowEquity SharesSEBI:02bd575e10a0c277f448671a570daaf779ccc731Canonical exit: 16 May 2024 (T+90)
- 293,100 shares@ ₹502.70100.0% of flowEquity SharesSEBI:b37cdd8ba2f94d5a49fb74a97839e7c5c1df993b
- 293,100 shares@ ₹502.7044.4% of flowEquity SharesSEBI:847f5a62d0394a89682a0a71b94a150697e75368Canonical exit: 25 Dec 2023 (T+90)
- 44,800 shares@ ₹525.239.2% of flowEquity SharesSEBI:25455e6c9d59fbc4556eb16be1c020f306f9e31fCanonical exit: 6 Dec 2023 (T+90)
- 38,000 shares@ ₹524.547.8% of flowEquity SharesSEBI:89ef68d5704818bd3c55d342421ea70dd5de2e94Canonical exit: 4 Dec 2023 (T+90)
- 18,200 shares@ ₹522.492.8% of flowEquity SharesSEBI:08bbcd909563805e6bceef2a07fd30e36f3d77b8Canonical exit: 4 Dec 2023 (T+90)
- 29,300 shares@ ₹512.084.4% of flowEquity SharesSEBI:313568328def5a73081ff07d481ab2df40853c3eCanonical exit: 30 Nov 2023 (T+90)
- 28,300 shares@ ₹516.385.7% of flowEquity SharesSEBI:74e8cc57a69f0f27dfb7051e0b5e7d192e315d09Canonical exit: 30 Nov 2023 (T+90)
- 28,300 shares@ ₹517.275.6% of flowEquity SharesSEBI:888fd97e4c866e173c4e12adbf737214110e64a7Canonical exit: 28 Nov 2023 (T+90)
- 29,500 shares@ ₹505.484.4% of flowEquity SharesSEBI:a1b86027e285537f567b2b0dfc2bbd709c3d47fdCanonical exit: 27 Nov 2023 (T+90)
- 29,700 shares@ ₹497.125.7% of flowEquity SharesSEBI:028d49e288d28ea3a831ecf51dacf7bf8c60fef7Canonical exit: 26 Nov 2023 (T+90)
- 30,500 shares@ ₹487.934.4% of flowEquity SharesSEBI:6bfb8a52ed6a296f3110f9272d01061514538668Canonical exit: 22 Nov 2023 (T+90)
- 31,000 shares@ ₹481.154.4% of flowEquity SharesSEBI:82b8ca8c3419360c37020cc875d27772c2eeef0dCanonical exit: 23 Nov 2023 (T+90)
- 31,500 shares@ ₹471.034.4% of flowEquity SharesSEBI:09b844d033f8e1c1c2e66dc292e3dc5b93d70ad8Canonical exit: 20 Nov 2023 (T+90)
- 32,200 shares@ ₹464.605.8% of flowEquity SharesSEBI:158ffa5c9feef81e5994b79fb6146e479ce55167Canonical exit: 21 Nov 2023 (T+90)
- 22,000 shares@ ₹407.342.7% of flowEquity SharesSEBI:becad599e80f055c8e02ae76b6eac9e9b64a17c4Canonical exit: 24 Sept 2023 (T+90)
- 10,000 shares@ ₹406.101.6% of flowEquity SharesSEBI:17ad00b622914654a2fbb428a0bbb1cf386b8109Canonical exit: 25 Sept 2023 (T+90)
- 23,500 shares@ ₹410.813.7% of flowEquity SharesSEBI:857af677030321f6228da5beb9f99deadc0968a7Canonical exit: 24 Sept 2023 (T+90)
- 25,000 shares@ ₹395.442.3% of flowEquity SharesSEBI:211d7e71abc34e7b7587c052a29f23bc334b4db9Canonical exit: 17 Sept 2023 (T+90)
25 of 137 declarations
About Lincoln Pharmaceuticals Limited
Lincoln Pharmaceuticals Limited is a company focused on the healthcare and pharmaceutical sector. It is listed on the XBOM market.
